Optiscan Biomedical

Developer of a continuous monitoring system for use in the surgical intensive care unit (SICU)

placeHayward, California, United States calendar_todayFounded 1994 groups67 employees language optiscancorp.com

Registered entities

Innovation

68 patent families (36 granted) — focus: Human necessities, Physics & computing, Chemistry & metallurgy, Operations & transport; filing pace slowing. Cited 13,836 times.

YearFilings
20128
201314
20149
20158
20167
201713
20188
20197
20208
20212
20261

Investor mix

18 investors on record; lead investors include Johnson & Johnson Innovation – JJDC, MedVenture Associates, Morgenthaler, Wexford Capital; 1 has since exited.

Investor typeCountShare
Venture capital844%
Private equity528%
Bank & private debt16%
Other / undisclosed422%
Coming soon